Shenxin Zeng

机构：Hangzhou Medical College · ORCID：0000-0003-3326-8380

发表论文 42 篇 · 总被引 875 次 · h-index 17

代表论文

Current advances and development strategies of orally bioavailable PROTACs (2023 · European Journal of Medicinal Chemistry · 被引 73)
The progress of molecules and strategies for the treatment of HBV infection (2023 · Frontiers in Cellular and Infection Microbiology · 被引 42)
Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy (2024 · Journal of Medicinal Chemistry · 被引 24)
Discovery of highly efficient CRBN-recruiting HPK1-PROTAC as a potential chemical tool for investigation of scaffolding roles in TCR signaling (2023 · Bioorganic Chemistry · 被引 23)
Discovery of a potent and selective PARP1 degrader promoting cell cycle arrest via intercepting CDC25C-CDK1 axis for treating triple-negative breast cancer (2023 · Bioorganic Chemistry · 被引 23)
Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody (2024 · European Journal of Medicinal Chemistry · 被引 19)